AI QA Growth Target healthcare providers expanding into AI-assisted radiation therapy planning and QA tools, leveraging Sun Nuclear’s recent AI-powered innovations and Oncospace acquisition to cross-sell integrated software and cloud-based solutions.

Expansion Opportunities Leverage Sun Nuclear’s active participation in major industry events (AAPM COMP meetings) and the recent acquisition to approach centers upgrading QA workflows, machine oversight, and adaptive radiotherapy capabilities.

Mid Market Focus Position Sun Nuclear as a comprehensive provider for 200–500 employee centers and mid-size cancer centers seeking scalable quality management, imaging, and therapy QA across diverse modalities.

Cloud and Data Promote cloud-based AI solutions and data integration from Oncospace to enable centralized QA analytics, remote monitoring, and easier technology adoption for centers aiming to improve patient safety and outcomes.

Part of Mirion Highlight the backing of Mirion Medical to pursue larger enterprise deals, joint solutions, and expanded service ecosystems, appealing to health systems seeking integrated equipment, software, and service offerings.